Cargando…
Exploiting the Stemness and Chemoresistance Transcriptome of Ewing Sarcoma to Identify Candidate Therapeutic Targets and Drug-Repurposing Candidates
SIMPLE SUMMARY: Ewing sarcoma is a cancer arising most frequently in teenagers and young adults. For many patients, outcomes are the same today as they were 30 years ago, emphasising the need for more effective treatments to eradicate the cells responsible for progression and relapse. These cells re...
Autores principales: | Roundhill, Elizabeth Ann, Pantziarka, Pan, Liddle, Danielle E., Shaw, Lucy A., Albadrani, Ghadeer, Burchill, Susan Ann |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9913297/ https://www.ncbi.nlm.nih.gov/pubmed/36765727 http://dx.doi.org/10.3390/cancers15030769 |
Ejemplares similares
-
RNA sequencing and functional studies of patient-derived cells reveal that neurexin-1 and regulators of this pathway are associated with poor outcomes in Ewing sarcoma
por: Roundhill, Elizabeth Ann, et al.
Publicado: (2021) -
Bioinformatics analysis of Ewing's sarcoma: Seeking key candidate genes and pathways
por: Zhang, Jinming, et al.
Publicado: (2019) -
Membrane expression of MRP-1, but not MRP-1 splicing or Pgp expression, predicts survival in patients with ESFT
por: Roundhill, E, et al.
Publicado: (2013) -
C/EBPβ-1 promotes transformation and chemoresistance in Ewing sarcoma cells
por: Gardiner, Jamie D., et al.
Publicado: (2017) -
Impact of ABC Transporters in Osteosarcoma and Ewing’s Sarcoma: Which Are Involved in Chemoresistance and Which Are Not?
por: Serra, Massimo, et al.
Publicado: (2021)